|
Targeting Integrin Pathways by GLPG-0187 in Medulloblastoma |
1R21CA267365-01 |
|
NCI |
2022 |
|
Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients |
1R21CA273782-01 |
|
NCI |
2022 |
|
Ms. LILAC: Muscle Mass in the Life and Longevity After Cancer (LILAC) Study |
1R37CA258761-01A1 |
|
NCI |
2022 |
|
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy |
1R37CA267905-01 |
|
NCI |
2022 |
|
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation |
1U01CA272268-01 |
|
NCI |
2022 |
|
Supplemental for Detection of Glycopeptides of MCI in Patient Serum |
3R01CA160254-11S1 |
|
NCI |
2022 |
|
sEcad as a novel target and therapy for IGF-1R expressing tumors |
3R01CA194409-08S1 |
|
NCI |
2022 |
|
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study |
3R01CA229815-04S1 |
|
NCI |
2022 |
|
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma |
3R01CA235162-04S1 |
|
NCI |
2022 |
|
Design of de novo interleukin mimics for targeted immunotherapy |
3R01CA240339-04S1 |
|
NCI |
2022 |